Cite
HARVARD Citation
Robak, T. et al. (n.d.). Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies. American journal of hematology. 93 (11), pp. 1402-1410. [Online].